Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Doctor-led NAD+ clinical trials in 2026 can be found on trusted sources like ClinicalTrials.gov, the NIH’s Clinical Research Trials portal, leading university medical centers, professional societies, longevity research institutes and biotech or pharmaceutical company listings.
There are several factors to consider—from IRB approval and investigator credentials to clear eligibility criteria and safety monitoring—so see below for detailed search strategies, evaluation checklists and step-by-step guidance on contacting coordinators and coordinating with your doctor.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme critical for cellular energy, DNA repair and overall metabolic health. As we age, NAD+ levels naturally decline, spurring interest in NAD+ supplementation and therapies to support healthy aging and longevity. Doctor-led NAD+ clinical trials are the gold standard for testing whether these therapies are both safe and effective. In this guide, you'll learn where and how to find reputable, doctor-led NAD+ and longevity clinical trials in 2026—without getting overwhelmed.
Clinical trials led by medical professionals offer several advantages:
Doctor-led trials are the cornerstone of evidence-based medicine. Unlike anecdotal reports or unregulated clinics, these studies systematically collect safety and efficacy data.
Finding the right trial takes some research. Below are the most trusted sources:
ClinicalTrials.gov
The largest public registry of privately and publicly funded trials worldwide.
NIH Research & Training
The National Institutes of Health often sponsors aging and metabolic health trials.
University Medical Centers
Leading research hospitals (e.g., Mayo Clinic, Cleveland Clinic, UCSF) regularly run anti-aging and metabolic trials.
Professional Societies
Organizations like the American Society for Nutrition or the Gerontological Society of America may list member-led trials.
Longevity Research Institutes
Private research institutes (e.g., Buck Institute, SENS Research Foundation) sometimes run open-enrollment studies.
Pharmaceutical and Biotech Companies
Companies developing NAD+ precursors (NR, NMN) often recruit participants directly.
Not all clinical trials are created equal. To ensure you're joining a high-quality, doctor-led study, look for:
If any of these elements are missing or vague, proceed with caution.
Clarify your goals and health status
Search targeted databases
Review eligibility
Contact trial coordinators
Discuss with your primary care provider
Complete screening assessments
Enroll and follow the protocol
• Keep a journal of symptoms, energy levels and any side effects.
• Stay in regular contact with the study team.
• Adhere strictly to dosing schedules, visit windows and lab requirements.
• Maintain open communication with your personal doctor.
Even if you don't meet the eligibility for one trial, ask coordinators about upcoming studies. Many sponsors maintain waitlists and new trials launch throughout the year.
Before or during any clinical trial, it's wise to stay proactive about your health. If you're experiencing new or concerning symptoms, use a Medically approved LLM Symptom Checker Chat Bot to get personalized insights and determine whether you should contact your trial coordinator or seek immediate medical attention. This intelligent tool helps you track changes, clarify concerns and prepare for more informed conversations with your healthcare team.
Doctor-led NAD+ clinical trials offer the most reliable route to understanding whether NAD+ therapies truly support healthy aging and longevity. By focusing on reputable registries, verifying IRB approval, and maintaining open dialogue with your healthcare providers, you can participate safely and effectively.
Always remember:
If you experience any worrisome or life-threatening symptoms at any point, speak to a doctor immediately. Your safety and well-being are paramount.
Good luck in your search for NAD+ and longevity clinical trials in 2026. Stay informed, stay proactive and never hesitate to seek professional medical advice.
(References)
* Nguyen, D. D., et al. (2023). NAD+ Precursors and NAD+ Boosting Therapies in Humans: A Systematic Review. *Journal of Clinical Pharmacology*, 63(1), 16-29.
* Rajman, S. B., et al. (2022). Nicotinamide adenine dinucleotide (NAD+) and its precursors in human health: Current research and therapeutic potential. *Journal of Clinical Investigation*, 132(11), e161833.
* Johnson, R. A., et al. (2022). The roles of NAD+ in human health: a systematic review of the literature. *Nutrients*, 14(15), 3122.
* Scheibye-Knudsen, F. A., et al. (2021). NAD+ in healthy aging and neurodegenerative disorders: A human perspective. *Neuroscience Research*, 168, 12-23.
* Braidy, J. D., et al. (2021). NAD+ supplementation in humans: emerging evidence and therapeutic implications. *Journal of Cellular and Molecular Medicine*, 25(16), 7545-7557.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.